The global market for bronchopulmonary dysplasia treatment was estimated to be worth USD 331 million in 2024 and is expected to grow to USD 559.21 million by the end of 2032, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to rise at a CAGR of 6%. The study examines the factors that will propel, impede, and...
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt